BIOQUAL, Inc. (OTCMKTS:BIOQ) shares rose 0.7% during trading on Tuesday . The stock traded as high as $35.25 and last traded at $35.25, approximately 500 shares were traded during mid-day trading. An increase of 87% from the average daily volume of 267 shares. The stock had previously closed at $35.00.
The company has a market cap of $31.60 million, a price-to-earnings ratio of 11.08 and a beta of 0.09. The firm has a 50-day moving average price of $33.11 and a 200 day moving average price of $35.20.
BIOQUAL (OTCMKTS:BIOQ) last issued its earnings results on Friday, September 13th. The company reported $1.30 EPS for the quarter. The firm had revenue of $11.56 million during the quarter.
BIOQUAL Company Profile (OTCMKTS:BIOQ)
Bioqual, Inc provides research, development, pre-clinical, consulting, and testing/assay services to commercial clients and government laboratories in the United States. The company provides research services in the areas of cancer, AIDS, hepatitis, influenza, immunology, transgenic, contraception, breeding and development of genetically defined animals, and neurobiology and behavior, as well as zika, dengue, malaria, respiratory syncytial virus, and other infectious diseases.
Receive News & Ratings for BIOQUAL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOQUAL and related companies with MarketBeat.com's FREE daily email newsletter.